Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H12N2O |
Molecular Weight | 188.2258 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1N(C(=O)C=C1C)C2=CC=CC=C2
InChI
InChIKey=VEQOALNAAJBPNY-UHFFFAOYSA-N
InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3
Molecular Formula | C11H12N2O |
Molecular Weight | 188.2258 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:58:01 UTC 2023
by
admin
on
Fri Dec 15 14:58:01 UTC 2023
|
Record UNII |
T3CHA1B51H
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
S02DA03
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
WHO-ATC |
N02BB71
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
WHO-VATC |
QS02DA03
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
FDA ORPHAN DRUG |
5284
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
WHO-VATC |
QN02BB01
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
WHO-ATC |
N02BB01
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
WHO-VATC |
QN02BB51
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
WHO-VATC |
QN02BB71
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
||
|
WHO-ATC |
N02BB51
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
31225
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
m1973
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | Merck Index | ||
|
DTXSID6021117
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
DB01435
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
T3CHA1B51H
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
D000983
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
1001
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | RxNorm | ||
|
2206
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
60-80-0
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
T3CHA1B51H
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
861
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
1040005
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
CHEMBL277474
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
413
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
PHENAZONE
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
Antipyrine
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
C76794
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
SUB09753MIG
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
100000085208
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY | |||
|
200-486-6
Created by
admin on Fri Dec 15 14:58:01 UTC 2023 , Edited by admin on Fri Dec 15 14:58:01 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |